For instance, these drugs can directly target the microbes, their metabolites, phages, or induced cytokines (e.g., IL‐17) to reshape the microbiome, thereby reducing tumorigenesis or slowing tumor progression.165, 249. Here, IL17A is linked to neoplasm.